Age-related macular degeneration (AMD) is a disease which causes the progressive deterioration of the macula, the part of your eye responsible for central vision. AMD is the number one cause of vision loss in people over 50 in North America, and it can affect your ability to recognize faces, drive, and read.
MEye Health is proud to offer genetic testing for AMD. The test determines which vitamin therapy is best for you and your probability of developing advanced AMD. Genetic testing is recommended for individuals with macular degeneration and their families.
We prescribe the recommended vitamins and use the Macular Pigment Optical Density (MPOD) device to measure the effectiveness of vitamin therapy. Low MPOD is a significant but modifiable risk factor for AMD.
Once identified, it can be monitored over time, enabling a proactive, preventative approach to AMD.